Index of reports
> Cases with Infection (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Campath side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Cystitis Haemorrhagic, Adenovirus Infection, Human Polyomavirus Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Vfend; Bactrim; Valganciclovir; Folic Acid
Possible Campath side effects in female
Reported by a lawyer from United States on 2012-07-20
Patient: female
Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Campath
End date: 2004-09-27
Thalidomide
Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid
Possible Campath side effects in female
Reported by a lawyer from United States on 2012-04-18
Patient: female
Reactions: Abdominal Pain, Vulval Ulceration, Upper Limb Fracture, Face Oedema, Hypotension, Phlebolith, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Depression, Bone Disorder, Discomfort, Impaired Healing, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Pneumonia, Stomatitis, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Atelectasis, Confusional State, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Hallucination, Sinusitis, Venous Lake, Pain in JAW, RIB Fracture, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Rash, Osteolysis, Deformity, Facial Pain, Pulmonary Fibrosis, Mucosal Inflammation, Anxiety, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: unk ukn, qmo
Indication: Multiple Myeloma
Campath
Dosage: unk
End date: 2004-09-27
Thalidomide
Other drugs received by patient: Darvocet-N 50; Magnesium; Aspirin; Augmentin '125'; Revlimid; Ativan; Calcium Carbonate; Hydralazine HCL; Prednisone TAB; COD-Liver OIL; Tylenol (Caplet); Chemotherapeutics NOS; Procrit / 00909301 /; Solu-Medrol; Lovastatin; Acyclovir; Neurontin; Peridex; MS Contin; Multivite; Mevacor; Scopolamine
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-30
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-02
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: C-Reactive Protein Increased, Pneumonia Bacterial, Chills, Febrile Neutropenia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd on days 1, 3 and 5
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-21
End date: 2011-08-12
Campath
Dosage: 30 mg, qd on days 1, 3 and 5
Start date: 2011-08-29
End date: 2011-09-12
Dexamethasone
Dosage: 40 mg, qdx4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-02
End date: 2011-09-05
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-09-02
Other drugs received by patient: Candesartan Cilexetil; Simvastatin; Nebivolol HCL; Marcumar; Pantoprazole; Novalgin; Pentacarinat; Tamsulosin HCL
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-26
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia Bacterial, C-Reactive Protein Increased, Chills, Febrile Neutropenia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-21
End date: 2011-08-12
Dexamethasone
Dosage: 40 mg, qdx4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-02
End date: 2011-09-05
Narcumar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-09-02
Other drugs received by patient: Novalgin; Pantoprazole; Tamsulosin HCL; Pentacarinat; Nebivolol HCL; Simvastin-Mepha
Possible Campath side effects in female
Reported by a physician from Belgium on 2011-10-17
Patient: female, weighing 37.4 kg (82.3 pounds)
Reactions: Pneumonia, Arthralgia, General Physical Health Deterioration, Decreased Appetite, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Other drugs received by patient: Voltaren; Acetaminophen; Tribvic; Xalatan; Laxoberon; D-Cure; Minoxidil; Oxycontin; Climen; Androcur; Deanxit; Oxycontin; Oxycontin; Calcium Sandoz; Morphine; Omeprazole; Artcoptic; Atroptic; Redomex; Dapsone
|